Get started
Author

Daniel R Owens

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
2020 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 4,774
PDF
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
2020 · Pedro M Folegatti, Katie J Ewer, et al. · The Lancet · 2,472
PDF
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine
2021 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 1,147
PDF
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
2022 · Alasdair P S Munro, Shuo Feng, et al. · The Lancet Infectious Diseases · 175
PDF
Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy
2009 · L. Monnier, C. Colette, et al. · Diabetologia · 136
PDF
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
2022 · Karin Hardt, An Vandebosch, et al. · The Lancet Infectious Diseases · 91
PDF
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
2022 · Saye H Khoo, Richard FitzGerald, et al. · The Lancet Infectious Diseases · 83
PDF
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme
2022 · Jeremy P. Carr, Jenny M. MacLennan, et al. · Clinical Microbiology and Infection · 79
PDF
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
2022 · Xinxue Liu, Alasdair P S Munro, et al. · Journal of Infection · 67
PDF
Effect of darkness on inner retinal hypoxia in diabetes
2002 · N Drasdo, Z Chiti, et al. · The Lancet · 54
COVAC1 Phase 2a Expanded Safety and Immunogenicity Study of a Self-Amplifying RNA Vaccine Against SARS-CoV-2
2022 · Alex J. Szubert, Katrina M. Pollock, et al. · EClinicalMedicine · 46
Paediatric nutrition risk scores in clinical practice: children with inflammatory bowel disease
2012 · A. E. Wiskin, D. R. Owens, et al. · Journal of Human Nutrition and Dietetics · 45
Safety and Immunogenicity of the ChadOx1 nCoV-19 (AZD1222) Vaccine in Children Aged 12-17 Years: A Preliminary Report of a Phase 2, Single-Blind, Randomised Controlled Trial (COV006)
2021 · Grace Li, Federica Cappuccini, et al. · The Lancet · 43
PDF
Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial
2023 · Xinxue Liu, Alasdair P S Munro, et al. · Journal of Infection · 40
Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH): a pragmatic, multicentre, open-label, two-arm, individually randomised, controlled trial
2025 · Cherry-Ann Waldron, Philip Pallmann, et al. · The Lancet Child & Adolescent Health · 25
PDF
Ten‐year experience of home parenteral nutrition in a single centre
2012 · Anthony E Wiskin, Caroline Cole, et al. · Acta Paediatrica · 22
Immunity to Streptococcus pyogenes and Common Respiratory Viruses at Age 0 to 4 Years After COVID-19 Restrictions
2025 · Kitt Dokal, Samuel Channon-Wells, et al. · JAMA Network Open · 18
PDF
COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study
2021 · Meera Shaunak, Ravin Patel, et al. · BMJ Open · 15
PDF
Algorithm for the introduction of rapid‐acting insulin analogues in patients with type 2 diabetes on basal insulin therapy
2009 · DR Owens, C van Schalkwyk, et al. · Practical Diabetes · 13
PDF
Incidence and progression of diabetic retinopathy within a private diabetes mellitus clinic in South Africa
2015 · RL Thomas, L Distiller, et al. · Journal of Endocrinology Metabolism and Diabetes of South Africa · 10
PDF
High frequency of paediatric facial nerve palsy due to Lyme disease in a geographically endemic region
2020 · Alasdair P.S. Munro, Robert B. Dorey, et al. · International Journal of Pediatric Otorhinolaryngology · 8
PDF
Insulin glargine and cancer: cause and effect unproven
2009 · DR Owens, J Rosenstock, et al. · Practical Diabetes · 8
The influence of aprotinin on regional absorption of soluble human insulin.
1988 · DR Owens, JP Vora, et al. · British Journal of Clinical Pharmacology · 8
PDF
Screening for diabetic retinopathy in general practice using 35mm colour transparency fundal photographs
1994 · RL Gibbins, F Kinsella, et al. · Practical Diabetes · 7
PDF
DIADEM: implementation of a comprehensive disease management programme for type 2 diabetes
2005 · S Luzio, C Tovar, et al. · Practical Diabetes · 6
PDF
Works count: 47
Citation count: 9,590
H-index: 18
I10-index: 21
Year
Topic
Type